12/20/2004 10:49:43 AM ET


    Surgeon Recommends Swiss Medica's O24'TM' to the Medical and Healthcare Community as a Replacement for
    Celebrex'R' and Bextra'R' in Selective Cases  

    Dec. 20, 2004--Swiss Medica (OTCBB:SWME - News) has accelerated its efforts to reach physicians and
    healthcare professionals with the Company's O24(TM) pain relief product, following Friday's warning by the
    Food and Drug Administration that physicians consider alternatives to Pfizer's popular arthritis medication, and
    Cox-2 inhibitor, Celebrex®; the Arthritis Foundation's recent caution in the use of any Cox-2 inhibitor; and a
    letter, to be published in the December 23rd issue of New England Journal of Medicine, by Vanderbilt University
    researchers, which warns clinicians against prescribing another Pfizer Cox-2 inhibitor, Bextra®, "except in
    extraordinary circumstances."

    "For the less severe cases of arthritis and other chronic pain ailments, I urge physicians, and other healthcare
    practitioners, to consider the non-synthetic nature of the O24(TM) pain relief product," said Allan N. Fields, D.O.,
    who recently edited an information guide about the O24(TM) Essential Oil Pain Neutralizer, entitled Natural Relief
    for Musculoskeletal Pain. "I recommend O24(TM) as a topical delivery system, which may help reduce the
    frequent use of oral pain medications. Many patients can apply O24(TM) to their pain area for fast-acting and
    long-lasting pain relief without interfering with their current prescription medication. O24(TM) may be a safe
    solution for many who worry about the increased risk of heart attack from the Cox-2 inhibitor class, or the
    deleterious impact on the stomach lining from anti-inflammatory medicines such as aspirin, ibuprofen or
    naproxen, as reported in the media."

    OFFER TO HEALTHCARE PROFESSIONALS
    In response to the worldwide concern about the Cox-2 inhibitor class, within the healthcare community and the
    media, Swiss Medica has commenced its Phase One dissemination of the booklet, Natural Relief for
    Musculoskeletal Pain, to the tens of thousands of North American physicians, surgeons, healthcare practitioners,
    hospitals and pharmacists. "This week, Swiss Medica has begun sending physicians and surgeons samples of
    the O24(TM) Essential Oil Pain Neutralizer with the information guide to offer healthcare practitioners a safe and
    natural alternative to the Cox-2 inhibitor class and other anti-inflammatory medicines," announced Chief
    Executive Officer Raghu Kilambi. "Complimentary information booklets and adequate product samples will also
    be immediately shipped to all hospitals, medical clinics, physicians, surgeons and other healthcare professionals
    who contact Swiss Medica and request them. We hope many will consider and test the O24(TM) pain relief
    product with their patients and clients to observe, first hand, the lightning efficacy of the Company's flagship
    product."

    Physicians and healthcare professionals should contact Swiss Medica at (877) 794-7633 or by email through
    customercare@024zone.com for a copy of the information booklet and samples of the O24(TM) pain relief
    product.

    About Dr. Allan N. Fields
    Currently the attending physician and surgeon of Sinai Medical Center, resident physician of 21st Century
    Radiation Centers, and attending physician for United Cerebral Palsy (Broward and Palm Beach counties), Dr.
    Fields previously served as Professor of Surgery at Barry University School of Podiatric Medicine, Associate
    Clinical Professor of Surgery at Nova Southeastern University, and Chairman of the Department of Surgery and
    Chief of General Surgery for Humana Hospital (South Broward). Dr. Fields was Chairman of the Speaker's
    Bureau of Public Education for the American Cancer Society (Dade County), and was honored by the national
    office of the American Cancer Society for notable service in saving lives. In 2004, Dr. Fields was honored by the
    American Association of Ringside Physicians as "Physician of the Year" and also awarded the Key to the City of
    Miami Beach. He is also active in sports medicine, serving as team physician to the USA Olympic Boxing Team
    (1993, 1996).

    About Swiss Medica Inc.
    Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
    market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be
    a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
    visit our websites at www.swissmedica.com and www.O24zone.com
    Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The
    O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting
    benefits by healthcare professionals in the United States, Canada and in Europe. O24 is widely available
    throughout Canada in leading pharmacies and natural food stores. It is available in the United States and
    elsewhere by visiting www.O24zone.com, for ordering details and store locators.

    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
    United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.